Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination medication consisting of metoclopramide and ketorolac used primarily for the treatment of acute migraine headaches in emergency department settings. This combination is sometimes referred to as part of a "migraine cocktail." Metoclopramide is an antiemetic and prokinetic agent that works by blocking dopamine receptors and stimulating gastrointestinal motility. Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) with potent analgesic, anti-inflammatory, and antipyretic properties. Research on the combination's effectiveness shows varying results, with some studies in children failing to show improved pain intensity compared to metoclopramide monotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on metoclopramide + ketorolac.